Four-Month Rifapentine Regimen With Moxifloxacin Noninferior for TB

THURSDAY, May 6, 2021 -- A four-month rifapentine-based regimen containing moxifloxacin is noninferior to a standard six-month regimen for treatment of tuberculosis, according to a study published in the May 6 issue of the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news